PDE5A and early-onset autosomal dominant Alzheimer disease: Icariin is a putative selective dual-target ache/PDE5 inhibitor that could be used to treat Alzheimer’s disease. Possess significant anti-AD properties in an indifferent of AD mouse models (Mao et al., 2018).